| Year |
Title |
Altmetric |
| 2022
|
Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
Inflammatory Bowel Diseases.
28:1893-1903.
2022
|
|
| 2022
|
Adherent invasive Escherichia coli in Crohn's disease: Guilt by association?.
Gut.
72:2-3.
2022
|
|
| 2022
|
Host Genetics But Not Commensal Microbiota Determines the Initial Development of Systemic Autoimmune Disease in BXD2 Mice.
Arthritis and Rheumatology.
74:634-640.
2022
|
|
| 2022
|
Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity.
Nature Medicine.
28:766-779.
2022
|
|
| 2021
|
Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
Gastroenterology.
161:522-535.e6.
2021
|
|
| 2020
|
Synchronization of mothers and offspring promotes tolerance and limits allergy.
JCI Insight.
5.
2020
|
|
| 2020
|
Identification of Prevotella Oralis as a possible target antigen in children with Enthesitis related arthritis.
Clinical Immunology.
216.
2020
|
|
| 2019
|
Challenges in IBD Research: Pragmatic Clinical Research.
Inflammatory Bowel Diseases.
25:S40-S47.
2019
|
|
| 2019
|
Decreased Fecal Bacterial Diversity and Altered Microbiome in Children Colonized With Clostridium difficile.
Journal of Pediatric Gastroenterology and Nutrition.
68:502-508.
2019
|
|
| 2019
|
Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritis.
Genes and Immunity.
20:158-166.
2019
|
|
| 2018
|
The PTEN Mutation in Cowden Syndrome: A Case Report.
American Journal of Gastroenterology.
113:s846-s847.
2018
|
|
| 2018
|
Expanded TCRβ CDR3 clonotypes distinguish Crohn’s disease and ulcerative colitis patients.
Mucosal Immunology.
11:1487-1495.
2018
|
|
| 2018
|
Adaptive immune education by gut microbiota antigens.
Immunology.
154:28-37.
2018
|
|
| 2017
|
Selective induction of homeostatic Th17 cells in the murine intestine by cholera toxin interacting with the microbiota.
Journal of Immunology.
199:312-322.
2017
|
|
| 2017
|
Moms, babies, and bugs in immune development.
F1000Research.
6.
2017
|
|
| 2016
|
Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.
Gastroenterology.
151:1061-1062.
2016
|
|
| 2016
|
Abdominal Pain With an Unusual Radiographic Image.
Gastroenterology.
151:241-242.
2016
|
|
| 2016
|
Commensal A4 bacteria inhibit intestinal Th2-cell responses through induction of dendritic cell TGF-β production.
European Journal of Immunology.
46:1162-1167.
2016
|
|
| 2016
|
Deletion of the toll-like receptor 5 gene per se does not determine the gut microbiome profile that induces metabolic syndrome: Environment trumps genotype.
PLoS One.
11.
2016
|
|
| 2015
|
Human seroreactivity to gut microbiota antigens.
Journal of Allergy and Clinical Immunology.
136:1378-1386.e5.
2015
|
|
| 2015
|
Interleukin (IL)-21 promotes intestinal IgA response to microbiota.
Mucosal Immunology.
8:1072-1082.
2015
|
|
| 2015
|
Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.
Journal of Travel Medicine.
22:242-250.
2015
|
|
| 2015
|
Host-microbiota interactions in the intestine
2015
|
|
| 2015
|
TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
European Journal of Immunology.
45:1010-1018.
2015
|
|
| 2014
|
Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis.
Arthritis Research and Therapy.
16.
2014
|
|
| 2014
|
Tlr4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+Tregsduring intestinal inflammation.
Journal of Leukocyte Biology.
96:895-905.
2014
|
|
| 2014
|
Lloyd F. Mayer, MD: A remembrance.
Mucosal Immunology.
7:205-209.
2014
|
|
| 2014
|
Downregulation of microRNA-107 in intestinal CD11c+ myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression.
European Journal of Immunology.
44:673-682.
2014
|
|
| 2014
|
Microbiota activation and regulation of innate and adaptive immunity.
Immunological Reviews.
260:206-220.
2014
|
|
| 2013
|
Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.
Inflammatory Bowel Diseases.
19:2744-2752.
2013
|
|
| 2013
|
ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis.
European Journal of Immunology.
43:1716-1726.
2013
|
|
| 2013
|
Innate lymphoid cells regulate CD4 + T-cell responses to intestinal commensal bacteria.
Nature.
498:113-117.
2013
|
|
| 2013
|
Basil Isaac Hirschowitz, MD.
Gastrointestinal Endoscopy.
77:677-678.
2013
|
|
| 2013
|
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.
Annual Review of Pathology: Mechanisms of Disease.
8:477-512.
2013
|
|
| 2012
|
Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis.
Journal of Immunology.
189:4666-4673.
2012
|
|
| 2012
|
Reciprocal interactions of the intestinal microbiota and immune system.
Nature.
489:231-241.
2012
|
|
| 2012
|
Host-microbiota interactions in inflammatory bowel disease.
Gut Microbes.
3.
2012
|
|
| 2012
|
Biomarkers of therapeutic response in the IL-23 pathway in inflammatory bowel disease.
Clinical and Translational Gastroenterology.
3.
2012
|
|
| 2012
|
So Long, Folks.
Clinical Gastroenterology and Hepatology.
10:573-574.
2012
|
|
| 2012
|
Regulation of Toll-like receptor 5 gene expression and function on mucosal dendritic cells.
PLoS One.
7.
2012
|
|
| 2012
|
Exam 1: Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment.
Clinical Gastroenterology and Hepatology.
10:e39-e40.
2012
|
|
| 2011
|
Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.
Journal of Immunology.
187:5879-5886.
2011
|
|
| 2011
|
Exam 1: Cirrhosis With Refractory Ascites: Serial Large Volume Paracentesis, TIPS, or Transplantation?.
Clinical Gastroenterology and Hepatology.
9:e121-e122.
2011
|
|
| 2011
|
Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.
Journal of Immunology Research.
2011.
2011
|
|
| 2011
|
CME Activities–Exams 1 and 2.
Clinical Gastroenterology and Hepatology.
9:e69-e70.
2011
|
|
| 2011
|
Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
Journal of Immunology.
186:6313-6318.
2011
|
|
| 2011
|
Treg cell-IgA axis in maintenance of host immune homeostasis with microbiota.
International Immunopharmacology.
11:589-592.
2011
|
|
| 2011
|
Exam 1: How Do I Handle the Patient With Noncardiac Chest Pain?.
Clinical Gastroenterology and Hepatology.
9:e34-e35.
2011
|
|
| 2011
|
Experimental inflammatory bowel disease: Insights into the host-microbiota dialog.
Immunity.
34:293-302.
2011
|
|
| 2011
|
Adaptive immunity in the host-microbiota dialog.
Mucosal Immunology.
4:15-21.
2011
|
|
| 2011
|
CME Activities#226;#128;#147;Exams 1 (2011-01).
Clinical Gastroenterology and Hepatology.
9:e6-e7.
2011
|
|
| 2011
|
IL-12 converts Foxp3(+) regulatory T cells to Foxp3(+)IFN-γ(+) T cells with inhibitory functions during induction of colitis.
Gastroenterology.
140:2031-43.
2011
|
|
| 2011
|
Interleukin-12 converts Foxp3+ regulatory T cells to interferonγ-producing Foxp3+ T cells that inhibit colitis.
Gastroenterology.
140:2031-2043.
2011
|
|
| 2010
|
Generation of mucosal dendritic cells from bone marrow reveals a critical role of retinoic acid.
Journal of Immunology.
185:5915-5925.
2010
|
|
| 2010
|
Exam 2: Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease.
Clinical Gastroenterology and Hepatology.
8:e109.
2010
|
|
| 2010
|
Exam 2: A 41-Year-Old Woman With Abdominal Complaints: Is It Food Allergy or Food Intolerance? How to Tell the Difference.
Clinical Gastroenterology and Hepatology.
8:e97.
2010
|
|
| 2010
|
Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis (The Journal of Experimental Medicine (2010) 207, 6 (1321-1332)).
Journal of Experimental Medicine.
207:1569.
2010
|
|
| 2010
|
Enterorhabdus caecimuris sp. nov., a member of the family Coriobacteriaceae isolated from a mouse model of spontaneous colitis, and emended description of the genus Enterorhabdus Clavel et al. 2009.
International Journal of Systematic and Evolutionary Microbiology.
60:1527-1531.
2010
|
|
| 2010
|
Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis.
Journal of Experimental Medicine.
207:1321-1332.
2010
|
|
| 2010
|
Exam 2: Factors That Predict Outcome of Abdominal Operations in Patients With Advanced Cirrhosis.
Clinical Gastroenterology and Hepatology.
8:e58.
2010
|
|
| 2010
|
Microbiota dual-faceted player in experimental colitis.
Gut Microbes.
1.
2010
|
|
| 2009
|
Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
European Journal of Immunology.
39:3134-3146.
2009
|
|
| 2009
|
Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells.
European Journal of Immunology.
39:3239-3250.
2009
|
|
| 2009
|
TGF-β promotes Th17 cell development through inhibition of SOCS3.
Journal of Immunology.
183:97-105.
2009
|
|
| 2009
|
Late Developmental Plasticity in the T Helper 17 Lineage.
Immunity.
30:92-107.
2009
|
|
| 2009
|
Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBiri and ASCA, and show reduced NF-κB activation.
Gut.
58:60-67.
2009
|
|
| 2008
|
Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease.
Inflammatory Bowel Diseases.
14:1641-1651.
2008
|
|
| 2008
|
III. Report of adaptive and regulatory immune responses workgroup.
Inflammatory Bowel Diseases.
14:694-696.
2008
|
|
| 2008
|
X. Challenges update workgroups.
Inflammatory Bowel Diseases.
14:706-708.
2008
|
|
| 2008
|
Peyer's patches as the inductive site for IgA responses.
Journal of Immunology.
180:1293-1294.
2008
|
|
| 2007
|
Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia.
Journal of Immunology.
179:5966-5976.
2007
|
|
| 2007
|
Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?.
Journal of Immunology.
179:5633-5638.
2007
|
|
| 2007
|
Isolation of flagellated bacteria implicated in Crohn's disease.
Inflammatory Bowel Diseases.
13:1191-1201.
2007
|
|
| 2007
|
A novel role for defensins in intestinal homeostasis: Regulation of IL-1β secretion.
Journal of Immunology.
179:1245-1253.
2007
|
|
| 2007
|
Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Inflammatory Bowel Diseases.
13:524-530.
2007
|
|
| 2007
|
CCFA microbial-host interactions workshop: Highlights and key observations.
Inflammatory Bowel Diseases.
13:600-619.
2007
|
|
| 2007
|
CCFA host-microbial interactions workshop: highlights and key observations.
Inflammatory Bowel Diseases.
13:600-19.
2007
|
|
| 2007
|
Fenofibrate Represses Interleukin-17 and Interferon-γ Expression and Improves Colitis in Interleukin-10-Deficient Mice.
Gastroenterology.
133:108-123.
2007
|
|
| 2007
|
Monoclonal Anti-Interleukin 23 Reverses Active Colitis in a T Cell-Mediated Model in Mice.
Gastroenterology.
132:2359-2370.
2007
|
|
| 2006
|
Alterations of T lymphocytes in inflammatory bowel diseases.
Advances in Experimental Medicine and Biology.
579:133-148.
2006
|
|
| 2006
|
From Cheese to Pharma: A Designer Probiotic for IBD.
Clinical Gastroenterology and Hepatology.
4:836-837.
2006
|
|
| 2006
|
Transforming growth factor-β induces development of the T H17 lineage.
Nature.
441:231-234.
2006
|
|
| 2006
|
Serum immune responses predict rapid disease progression among children with Crohn's disease: Immune responses predict disease progression.
American Journal of Gastroenterology.
101:360-367.
2006
|
|
| 2006
|
From Cheese to Pharma: A Designer Probiotic for IBD.
Clinical Gastroenterology and Hepatology.
4:836-7.
2006
|
|
| 2006
|
Molecular approaches to the role of the microbiota in inflammatory bowel disease.
Annals of the New York Academy of Sciences.
1072:39-51.
2006
|
|
| 2006
|
Tight Mucosal Compartmentation of the Murine Immune Response to Antigens of the Enteric Microbiota.
Gastroenterology.
130:2050-2059.
2006
|
|
| 2005
|
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
Immunological Reviews.
206:260-276.
2005
|
|
| 2005
|
National Institutes of Health Consensus Development Conference statement on Celiac Disease, June 28-30, 2004.
Gastroenterology.
128.
2005
|
|
| 2005
|
Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.
Journal of Immunology.
174:2787-2795.
2005
|
|
| 2005
|
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease.
Alimentary Pharmacology and Therapeutics.
21:373-384.
2005
|
|
| 2005
|
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Gastroenterology.
128:2020-2028.
2005
|
|
| 2005
|
Cdcs1, a major colitogenic locus in mice, regulates innate and adaptive immune response to enteric bacterial antigens.
Gastroenterology.
129:1473-1484.
2005
|
|
| 2005
|
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
Immunological Reviews.
206:260-76.
2005
|
|
| 2004
|
Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells.
Journal of Immunology.
173:7249-7258.
2004
|
|
| 2004
|
Anti-interleukin-12 antibody for active Crohn's disease.
New England Journal of Medicine.
351:2069-2079.
2004
|
|
| 2004
|
Refined histopathologic scoring system improves power to detect colitis QTL in mice.
Mammalian Genome.
15:865-871.
2004
|
|
| 2004
|
New developments in experimental models of inflammatory bowel disease.
Current Opinion in Gastroenterology.
20:360-367.
2004
|
|
| 2004
|
Bacterial flagellin is a dominant antigen in Crohn disease.
Journal of Clinical Investigation.
113:1296-1306.
2004
|
|
| 2004
|
Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.
Annals of the New York Academy of Sciences.
1029:319-320.
2004
|
|
| 2004
|
Early upregulation of T cell IL-10 production plays an important role in oral tolerance induction.
Annals of the New York Academy of Sciences.
1029:319-20.
2004
|
|
| 2004
|
Gene disruption and immunity in experimental colitis.
Inflammatory Bowel Diseases.
10.
2004
|
|
| 2004
|
New developments in experimental inflammatory bowel disease.
Current Opinion in Gastroenterology.
20:360-7.
2004
|
|
| 2004
|
Oral tolerance in humans: Failure to suppress an existing immune response by oral antigen administration.
Annals of the New York Academy of Sciences.
1029:299-309.
2004
|
|
| 2004
|
Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration.
Annals of the New York Academy of Sciences.
1029:299-309.
2004
|
|
| 2004
|
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs.
Inflammatory Bowel Diseases.
10:1-14.
2004
|
|
| 2004
|
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays..
Inflammatory Bowel Diseases.
10:1-14.
2004
|
|
| 2003
|
Challenges in IBD research: Updating the scientific agendas.
Inflammatory Bowel Diseases.
9:137-153.
2003
|
|
| 2003
|
Probiotics and immune regulation of inflammatory bowel diseases
2003
|
|
| 2003
|
Probiotics and immune regulation of inflammatory bowel diseases.
2003
|
|
| 2002
|
Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora.
Journal of Immunology.
169:6112-6119.
2002
|
|
| 2002
|
Genes, microbes, and T cells - New therapeutic targets in Crohn's disease.
New England Journal of Medicine.
346:614-616.
2002
|
|
| 2002
|
T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis.
Journal of Experimental Medicine.
195:71-84.
2002
|
|
| 2002
|
Understanding immune-microbial homeostasis in intestine.
Immunologic Research.
26:87-94.
2002
|
|
| 2001
|
Effects of cholera toxin on macrophage production of co-stimulatory cytokines..
European Journal of Immunology.
31:64-71.
2001
|
|
| 2001
|
Mechanisms of immune tolerance to food antigens in humans.
Clinical Immunology.
101:158-168.
2001
|
|
| 2000
|
Colitis induced by enteric bacterial antigen-specific CD4+ T cells requires CD40-CD40 ligand interactions for a sustained increase in mucosal IL-12.
Journal of Immunology.
165:2173-2182.
2000
|
|
| 2000
|
Commensal bacteria as targets in Crohn's disease.
Gastroenterology.
119:254-257.
2000
|
|
| 2000
|
Genes, bugs, and T cells : New Insights into the Pathogenesis of Inflammatory Bowel Disease.
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.
97:A11-A20.
2000
|
|
| 2000
|
Heritable susceptibility for colitis in mice induced by IL-10 deficiency.
Inflammatory Bowel Diseases.
6:290-302.
2000
|
|
| 2000
|
Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.
Gastroenterology.
119:724-733.
2000
|
|
| 2000
|
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease.
Gastroenterology.
119:1473-1482.
2000
|
|
| 2000
|
The C3H/HeJBir mouse model: A high susceptibility phenotype for colitis.
International Reviews of Immunology.
19:63-75.
2000
|
|
| 1999
|
Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR.
International Immunology.
11:1253-1263.
1999
|
|
| 1999
|
Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans.
Journal of Immunology.
162:5173-5177.
1999
|
|
| 1999
|
Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice.
Genomics.
55:147-156.
1999
|
|
| 1999
|
Intestinal IgA: Novel views on its function in the defence of the largest mucosal surface.
Gut.
44:2-5.
1999
|
|
| 1998
|
pANCA represents a cross-reactivity to enteric bacterial antigens.
Journal of Clinical Immunology.
18:153-160.
1998
|
|
| 1998
|
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease..
Journal of Experimental Medicine.
187:855-864.
1998
|
|
| 1998
|
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease.
Journal of Experimental Medicine.
187:855-864.
1998
|
|
| 1998
|
Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.
American Journal of Physiology.
274.
1998
|
|
| 1998
|
Experimental models to study molecular mechanisms underlying intestinal disease. Proceedings of Symposium Intestinal Plasticity in Health and Disease.
Annals of the New York Academy of Sciences.
859:85-95.
1998
|
|
| 1998
|
Experimental models to study molecular mechanisms underlying intestinal inflammation.
Annals of the New York Academy of Sciences.
859:85-95.
1998
|
|
| 1998
|
Regional differences in L-selectin expression in murine intestinal lymphocytes.
Gastroenterology.
114:965-974.
1998
|
|
| 1998
|
Role of mucosal adjuvants in mucosal immunization.
Current Opinion in Gastroenterology.
14:483-487.
1998
|
|
| 1997
|
Spontaneously Colitic C3H/HeJBir Mice Demonstrate Selective Antibody Reactivity to Antigens of the Enteric Bacterial Flora.
Journal of Immunology.
159:44-52.
1997
|
|
| 1997
|
The Mucosal Adjuvanticity of Cholera Toxin Involves Enhancement of Costimulatory Activity by Selective Up-Regulation of B7.2 Expression.
Journal of Immunology.
159:5301-5308.
1997
|
|
| 1997
|
Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
European Journal of Immunology.
27:2720-2725.
1997
|
|
| 1997
|
Single-cell analyses of CD4+ T cells from αβ T cell receptor-transgenic mice: A distinct mucosal cytokine phenotype in the absence of transgene-specific antigen.
European Journal of Immunology.
27:1774-1781.
1997
|
|
| 1997
|
Advances in mucosal immunity.
Drugs.
54:13-14.
1997
|
|
| 1997
|
In defense of mucosal surfaces: Regulation and manipulation of the mucosal immune system.
Advances in Experimental Medicine and Biology.
412:373-385.
1997
|
|
| 1997
|
Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease.
Gastroenterology.
113:383-389.
1997
|
|
| 1996
|
Cholera toxin enhances costimulatory activity of macrophages by differentially regulating b7.1 and b7.2 expression
1996
|
|
| 1996
|
Differences in phenotypes and activation markers in different compartments of the intestine
1996
|
|
| 1996
|
In vivo analysis of CD4+ T cell responses to oral immunization
1996
|
|
| 1996
|
Kinetics of cytokine expression during healing of acute colitis in mice.
American Journal of Physiology.
271.
1996
|
|
| 1996
|
Mucosally activated circulating human T-cells express the gut homing receptor α4β7
1996
|
|
| 1996
|
Multiple mechanisms of oral tolerance to food antigens in humans
1996
|
|
| 1996
|
Tolerization of ovalbumin-specific αβ-tcr transgenic cells in adoptively transferred mice by the feeding of ovalbumin
1996
|
|
| 1996
|
Identification of an immunodominant T cell epitope on cholera toxin.
European Journal of Immunology.
26:2587-2594.
1996
|
|
| 1996
|
The effects of immunosuppressive agents on cytokines.
Alimentary Pharmacology and Therapeutics.
10:100-105.
1996
|
|
| 1996
|
Persistent Clonal Expansions of Peripheral Blood CD4+ Lymphocytes in Chronic Inflammatory Bowel Disease.
Journal of Immunology.
157:3183-3191.
1996
|
|
| 1996
|
Hapten-Induced Model of Murine Inflammatory Bowel Disease: Mucosal Immune Responses and Protection by Tolerance.
Journal of Immunology.
157:2174-2185.
1996
|
|
| 1996
|
Kinetics of cytokine expression during healing of acute colitis in mice..
American Journal of Physiology.
271:G130-G136.
1996
|
|
| 1996
|
An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial.
ACP journal club.
124:204-211.
1996
|
|
| 1996
|
Immunology of inflammatory bowel disease.
Current Opinion in Gastroenterology.
12:340-344.
1996
|
|
| 1996
|
Immunology of inflammatory bowel disease.
Current Opinion in Gastroenterology.
12:340-4.
1996
|
|
| 1996
|
Induction of tolerance in humans. Effectiveness of oral and nasal immunization routes.
Annals of the New York Academy of Sciences.
778:194-201.
1996
|
|
| 1996
|
Induction of tolerance in humans: Effectiveness of oral and nasal immunization routes.
Annals of the New York Academy of Sciences.
778:194-201.
1996
|
|
| 1996
|
Kinetics of cytokine expression during healing of acute colitis in mice
1996
|
|
| 1996
|
Oral antigen delivery via a multiple emulsion system enhances oral tolerance.
Annals of the New York Academy of Sciences.
778:156-62.
1996
|
|
| 1996
|
Oral-antigen delivery by way of a multiple emulsion system enhances oral tolerance.
Annals of the New York Academy of Sciences.
778:156-162.
1996
|
|
| 1996
|
Persistent clonal expansions of CD4+ lymphocytes implicate specific chronic antigen exposure in the pathogenesis of inflammatory bowel disease.
Journal of Immunology.
157:3183-91.
1996
|
|
| 1996
|
Regulation of mucosal immune responses - The missing link in IBD?.
Canadian Journal of Gastroenterology and Hepatology.
10:105-109.
1996
|
|
| 1996
|
The basis of current and future therapy for inflammatory bowel disease.
American Journal of Medicine.
100:656-662.
1996
|
|
| 1996
|
The effects of immunosuppressive agents on cytokines.
Alimentary Pharmacology and Therapeutics.
100-5.
1996
|
|
| 1996
|
Why doesn't cyclosporine work in Crohn's disease?.
Inflammatory Bowel Diseases.
2:311-312.
1996
|
|
| 1995
|
Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine.
Journal of Immunology.
154:5611-5619.
1995
|
|
| 1995
|
Experimental models of inflammatory bowel disease.
Gastroenterology.
109:1344-1367.
1995
|
|
| 1995
|
Intraperitoneal administration of tetanus toxoid elicits a specific response of antibody-secreting cells in the peritoneal cavity.
Advances in experimental biology.
371A:103-6.
1995
|
|
| 1995
|
Intraperitoneal administration of tetanus toxoid elicits a specific responses of antibody-secreting cells in the peritoneal cavity.
Advances in Experimental Medicine and Biology.
371:103-106.
1995
|
|
| 1995
|
Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit.
Journal of Immunology.
154:1032-1040.
1995
|
|
| 1995
|
Oral tolerance in humans: T cell but not B cell tolerance to a soluble protein antigen
1995
|
|
| 1995
|
Oral tolerance in humans: T cell but not B cell tolerance to a soluble protein antigen.
Advances in Experimental Medicine and Biology.
371:1225-1228.
1995
|
|
| 1995
|
The effect of immunosuppressive agents on monocyte generation and cytokine expression.
Inflammatory Bowel Diseases.
1:266-275.
1995
|
|
| 1995
|
Transient protein S deficiency associated with cerebral venous thrombosis in active ulcerative colitis.
American Journal of Gastroenterology.
90:313-315.
1995
|
|
| 1994
|
Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding.
Journal of Immunology.
152:4663-4670.
1994
|
|
| 1994
|
Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.
Gastroenterology.
107:1643-1652.
1994
|
|
| 1994
|
Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.
Clinical and Experimental Immunology.
96:356-363.
1994
|
|
| 1994
|
Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice.
Gastroenterology.
107:1726-1735.
1994
|
|
| 1993
|
Helper t cell subsets for immunoglobulin a responses: Oral inmaunization with tetanus toxoid and cholera toxinn as adjuvant selectively induces th2 cells in mucosa associated tissues.
Journal of Experimental Medicine.
178:1309-1320.
1993
|
|
| 1993
|
Low-dose oral methotrexate in refractory inflammatory bowel disease.
Digestive Diseases and Sciences.
38:1851-1856.
1993
|
|
| 1993
|
Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.
Infection and Immunity.
61:48-55.
1993
|
|
| 1993
|
Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: Mode of action and augmenting effect of inflammatory cytokines.
Infection and Immunity.
61:4637-4644.
1993
|
|
| 1993
|
Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
Journal of Immunology.
150:3274-3283.
1993
|
|
| 1993
|
Optimizing oral vaccines: Induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Infection and Immunity.
61:4272-4279.
1993
|
|
| 1993
|
Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.
Infection and Immunity.
61:384-390.
1993
|
|
| 1992
|
Cells and cytokines in mucosal immunity and inflammation.
Gastroenterology Clinics of North America.
21:347-366.
1992
|
|
| 1992
|
Cholera toxin as a mucosal adjuvant: Effects of H-2 major histocompatibility complex and lps genes.
Infection and Immunity.
60:2874-2879.
1992
|
|
| 1991
|
Interleukin-10 and Counting. Selected Summary.
Gastroenterology.
100:1778-80.
1991
|
|
| 1991
|
Interleukin-10 and counting ....
Gastroenterology.
100:1778.
1991
|
|
| 1991
|
Preface.
Gastroenterology Clinics of North America.
20.
1991
|
|
| 1990
|
Cyclosporine in Crohn's disease-Low doses won't do it.
Gastroenterology.
98:1383-1384.
1990
|
|
| 1990
|
Activation of cholera toxin-specific T cells in vitro.
Infection and Immunity.
58:3711-3716.
1990
|
|
| 1990
|
Cyclosporine in Crohn's Disease-- Low Doses Won't Do It. Selected Summary.
Gastroenterology.
98:1383-4.
1990
|
|
| 1990
|
Cytokines can make you sick - or keep you well. Selected Summary..
Gastroenterology.
98:536-8.
1990
|
|
| 1990
|
Cytokines can make you sick-Or keep you well.
Gastroenterology.
98:536-537.
1990
|
|
| 1990
|
Cytokines can make you sick-Or keep you well.
Gastroenterology.
98:1095-1096.
1990
|
|
| 1990
|
Do organ-specific suppressor T cells prevent autoimmune gastritis?.
Gastroenterology.
98:226-229.
1990
|
|
| 1990
|
Primary Biliary Cirrhosis in a Mouse? Selected Summary.
Gastroenterology.
99:1181-3.
1990
|
|
| 1990
|
Primary biliary cirrhosis in a mouse?.
Gastroenterology.
99:1181-1182.
1990
|
|
| 1989
|
Regulation of IgA synthesis and immune response by T cells and interleukins.
Journal of Clinical Immunology.
9:175-199.
1989
|
|
| 1989
|
Interleukin-5 stimulates IgA secretion. Selected Summary..
Gastroenterology.
97:946-9.
1989
|
|
| 1989
|
Interleukin-5 stimulates immunoglobulin a secretion.
Gastroenterology.
96:946-947.
1989
|
|
| 1989
|
Regulation of IgA Synthesis and Immune Response by T Cells and Interleukins.
Journal of Clinical Immunology.
9:175-99.
1989
|
|
| 1989
|
Specialized receptors for antigens on gut epithelial T cells.
Gastroenterology.
97:1341-1342.
1989
|
|
| 1989
|
Specialized receptors for antigens on gut epithelial T cells. Selected Summary.
Gastroenterology.
97:1341-2.
1989
|
|
| 1988
|
A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.
Immunotechnology : an international journal of immunological engineering.
110:85-91.
1988
|
|
| 1988
|
Collagen content and types in normal intestine and in the strictures of Crohn's disease.
Gastroenterology.
94:251-65.
1988
|
|
| 1988
|
Collagen content and types in the intestinal strictures of Crohn's disease.
Gastroenterology.
94:257-265.
1988
|
|
| 1988
|
Intestinal IgA system.
Immunology and Allergy Clinics of North America.
8:349-368.
1988
|
|
| 1988
|
Regulatory activity of the human CD8+ cell subset: a comparison of CD8+ cells from the intestinal lamina propria and blood.
European Journal of Immunology.
18:21-27.
1988
|
|
| 1987
|
Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin.
Journal of Immunology.
139:3764-3770.
1987
|
|
| 1987
|
Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.
Journal of Immunology.
138:4381-4386.
1987
|
|
| 1987
|
Collagen synthesis by human intestinal smooth muscle cells in culture.
Gastroenterology.
92:400-405.
1987
|
|
| 1987
|
Ir gene control of the murine secretory IgA response to cholera toxin.
European Journal of Immunology.
17:425-428.
1987
|
|
| 1986
|
Intestinal immunity and inflammation: Recent progress.
Gastroenterology.
91:746-768.
1986
|
|
| 1985
|
Genetic control of the murine immune response to cholera toxin.
Journal of Immunology.
135:930-932.
1985
|
|
| 1985
|
Abnormal Accumulation of Basement Membrane (Type IV) and Cytoskeletal (Type V) Collagens in the Strictures of Crohn's Disease: The Probable Role of Intestinal Smooth Muscle Cells.
Annals of the New York Academy of Sciences.
460:439-442.
1985
|
|
| 1985
|
Genetic control of the immune response to cholera toxin
1985
|
|
| 1985
|
T cell-B cell regulation in the intestinal lamina propria in Crohn's disease.
Gastroenterology.
89:321-327.
1985
|
|
| 1984
|
Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
Journal of Immunology.
133:2892-2897.
1984
|
|
| 1984
|
A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.
Immunotechnology : an international journal of immunological engineering.
67:101-108.
1984
|
|
| 1984
|
Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen
1984
|
|
| 1984
|
Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Journal of Immunology.
132:2736-2741.
1984
|
|
| 1984
|
Hypogammaglobulinemia Due to Abnormal Suppressor T-Cell Activity in Crohn's Disease.
Gastroenterology.
86:569-576.
1984
|
|
| 1984
|
Isolation and Culture of Human Intestinal Smooth Muscle Cells.
Experimental Biology and Medicine.
176:503-507.
1984
|
|
| 1984
|
Isolation, culture and characterization of human intestinal smooth muscle cells (HISMC)
1984
|
|
| 1983
|
Helper T cell activity in intestinal lamina propria.
Annals of the New York Academy of Sciences.
409:230-230.
1983
|
|
| 1983
|
Human host response to Giardia lamblia. II. Antibody-dependent killing in vitro.
Cellular Immunology.
82:308-315.
1983
|
|
| 1983
|
T‐HELPER CELL ACTIVITY IN INTESTINAL LAMINA PROPRIA.
Annals of the New York Academy of Sciences.
409:230-237.
1983
|
|
| 1982
|
Human host response to Giardia lamblia. I. Spontaneous killing by mononuclear leukocytes in vitro.
Journal of Immunology.
128:1372-1376.
1982
|
|
| 1981
|
Immunoregulatory function of T cells activated in the autologous mixed lymphocyte reaction.
Journal of Immunology.
127:2605-2609.
1981
|
|
| 1981
|
Covert suppressor T cells in Crohn's disease.
Gastroenterology.
80:1513-1521.
1981
|
|
| 1980
|
Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis.
Gastroenterology.
79:242-254.
1980
|
|
| 1980
|
An evaluation of total parenteral nutrition in the management of inflammatory bowel disease.
Digestive Diseases and Sciences.
25:42-48.
1980
|
|
| 1980
|
Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis.
Journal of Clinical Investigation.
66:1305-1310.
1980
|
|
| 1980
|
Tissue distribution of IgA receptor-bearing cells in mouse and guinea pig with special reference to the lymphoid population of the gastrointestinal tract.
Cellular Immunology.
55:106-113.
1980
|
|
| 1979
|
T-cell regulation of murine IgA synthesis.
Journal of Experimental Medicine.
149:632-643.
1979
|
|
| 1979
|
Liver Failure With Steatonecrosis After Jejunoileal Bypass: Recovery With Parenteral Nutrition and Reanastomosis.
JAMA Internal Medicine.
139:289-292.
1979
|
|
| 1979
|
Liver failure with steatonecrosis after jejunoileal bypass.
Archives of Internal Medicine.
139:289-289.
1979
|
|
| 1978
|
Leukocytic endogenous mediator in Crohn's disease.
Infection and Immunity.
22:637-639.
1978
|
|
| 1977
|
Liver failure with alcoholic like hyaline after jejuno ileal bypass; reversal by parenteral nutrition and reanastomosis.
Gastroenterology.
72.
1977
|
|
| 1977
|
Small Intestinal Injury in the Graft Versus Host Reaction: An Innocent Bystander Phenomenon.
Gastroenterology.
72:886-889.
1977
|
|
| 1976
|
Reversal of Growth Arrest in Adolescents with Crohn's Disease After Parenteral Alimentation.
Gastroenterology.
70:1017-1021.
1976
|
|
| 1975
|
Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography.
Gastroenterology.
69:507-510.
1975
|
|
